QI Recommendations. par Anna G. Mack (22001527)

Sujets:

Demographic Information (N<i> </i>= 26 Participants). par Anna G. Mack (22001527)

Sujets:

CLIMEX parameter values used for modelling fall armyworm (from [2]). par Rodney N. Nagoshi (3720304)

Sujets:

Portion of the <i>Tpi</i> gene containing the TpiI4a200 segment of the TpiI4 intron. par Rodney N. Nagoshi (3720304)

Sujets:

Emergent Conceptual Model for the Participant Experience in CHIM Trials. par Anna G. Mack (22001527)

Sujets:

Distribution of the COIB CSh haplotypes in collections from Mexico and Texas. par Rodney N. Nagoshi (3720304)

Sujets:

Distribution of the TpiI4a200 haplotypes in collections from Mexico and Texas. par Rodney N. Nagoshi (3720304)

Sujets:

Source information for collections. par Rodney N. Nagoshi (3720304)

Sujets:

CLIMEX modeling analysis of surveyed region. par Rodney N. Nagoshi (3720304)

Sujets:

Distribution of major corn production sites in Mexico and projected single night dispersion pattern during the summer and winter mid-season months. par Rodney N. Nagoshi (3720304)

Sujets:

Maximum-likelihood phylogeny of TpiI4a200 from 173 larval specimens from Argentina, Brazil, and Florida ([ par Rodney N. Nagoshi (3720304)

Sujets:

Projected northward movement of FAW through Mexico. par Rodney N. Nagoshi (3720304)

Sujets:

Iterative Data Collection and Analysis Process. par Anna G. Mack (22001527)

Sujets:

Trend of total annual payments from pharmaceutical companies to breast cancer specialists in Japan, 2016–2019. par Yudai Kaneda (12337733)

Sujets:

Overview of pharmaceutical payments to breast cancer specialists in Japan, 2016–2019. par Yudai Kaneda (12337733)

Sujets:

S1 Data - par Yudai Kaneda (12337733)

Sujets:

Total payments and annual changes for top 10 pharmaceutical companies to breast cancer specialists in Japan, 2016–2019. par Yudai Kaneda (12337733)

Sujets:

New drug introductions and changes in pharmaceutical company payments to breast cancer specialists in Japan, 2016–2019. par Yudai Kaneda (12337733)

Sujets:

Payment data to breast cancer specialists from pharmaceutical companies during the study period. par Yudai Kaneda (12337733)

Sujets:

Trends of pharmaceutical payment breakdowns across four years. par Yudai Kaneda (12337733)

Sujets: